Showing results (11-20 of 278) with videos related to
Sort By:
Pageof 28
Journal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
Major Changes in Systemic Therapy for Advanced MelanomaJohn A ThompsonJournal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Treatment options expanding for advanced melanomaJohn A ThompsonJournal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Agents make "preferred list" in metastatic melanomaJohn A ThompsonJournal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
New NCCN Guidelines: Recognition and Management of Immunotherapy-Related ToxicityJohn A ThompsonClinical Toxicology (Philadelphia, Pa.)|February 20, 2025
Quantitative analysis of recreational psychoactive mushroom gummies in Portland, OregonMatthew S Correia, Mikayla J Gonzaga, Courtney Temple, et al.Clinical Toxicology (Philadelphia, Pa.)|November 14, 2022
Characteristics of ivermectin toxicity in patients taking veterinary and human formulations for the prevention and treatment of COVID-19Ruby Hoang, Courtney Temple, Matthew S Correia, et al.Developmental Neurobiology|April 20, 2007
HVC microlesions do not destabilize the vocal patterns of adult male zebra finches with prior ablation of LMANJohn A Thompson, Frank JohnsonJournal of Neurophysiology|October 4, 2013
Activity in mouse pedunculopontine tegmental nucleus reflects action and outcome in a decision-making taskJohn A Thompson, Gidon FelsenJournal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Systemic therapy for metastatic melanoma in 2012: dawn of a new eraShailender Bhatia, John A ThompsonAdvances in Therapy|January 28, 2009
Temsirolimus in patients with advanced renal cell carcinoma: an overviewShailender Bhatia, John A ThompsonPageof 28